Search clinical trials for: DBT-Danggui Buxue Tang

Total 11 results

Chinese University of Hong Kong

Completed

Study the Effect of Danggui Buxue Tang on Menopausal Symptoms

Menopause

China
Chinese University of Hong Kong

Completed

Dose Finding Study of Danggui Buxue Tang (Herbal Formula)on the Treatment of Menopausal Symptoms

Postmenopausal

China
Sheng-Teng Huang

Completed

Development of PHY606 as Adjunct Therapy for Anemia Patients

Anemia | Herbal Interaction

Taiwan
China Medical University Hospital

Unknown

To Investigate the Molecular Mechanism of Traditional Chinese Medicine Constitution Using Next-generation Sequencing in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Taiwan
Kaohsiung Medical University Chung-Ho Memorial...

Completed

Effects of Danggui Buxue Tang on Blood Biochemical Parameters in Male Recreational Runners

Inflammation | Fatigue | Hemolysis | Oxidative Stress | Iron Deficiency | Sports Anemia

Taiwan
Gachon University Gil Oriental Medical Hospital
Kyung Hee University Hospital at Gangdong; DongGuk University; Kyunghee University... and other collaborators

Completed

Efficacy and Safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean Patients With Cold Hypersensitivity in the Hands

Cold Hypersensitivity

Korea, Republic of
Shanghai Jiao Tong University School of Medicine

Completed

Study of Danggui Buxue Decoction in Preventing Neutropenia (DIPE)

Febrile Neutropenia | Grade 3/4 Neutropenia

China
OcuTherix, Inc.

Terminated

Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension

Primary Open-angle Glaucoma (POAG) | Ocular Hypertension (OHT)

Philippines
Novartis

Completed

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

Type 2 Diabetes Mellitus | Impaired Glucose Tolerance

United States, Canada, Finland, Australia, Germany, India, Italy
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia

United States
Julio Ramirez
University of Louisville

Terminated

Patients Response to Early Switch To Oral:Osteomyelitis Study (PRESTO:Osteo)

Osteomyelitis

United States

Search clinical trials for: DBT-Danggui Buxue Tang

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations